Proton beam trial aims to zap inoperable tumors with higher, safer doses
NCT ID NCT07173972
Summary
This study is testing whether a newer type of radiation therapy, called proton beam therapy, can be given at a higher dose to better control inoperable soft tissue sarcomas. The goal is to see if this approach stops tumor growth for at least two years without increasing side effects compared to standard radiation. The trial will include 40 adult patients in Norway and will also collect blood and tissue samples to look for clues about how patients respond to treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIPOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Haukeland University Hospital
NOT_YET_RECRUITINGBergen, Norway
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oslo University Hospital
RECRUITINGOslo, Norway
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.